10x Genomics (TXG) Other Accumulated Expenses (2018 - 2026)

10x Genomics has disclosed Other Accumulated Expenses across 9 years of filings, most recently posting $7.1 million for Q2 2026.

• In Q2 2026, Other Accumulated Expenses fell 44.81% year-over-year to $7.1 million; the TTM figure through Jun 2026 stood at $7.1 million (down 44.81% YoY), while the FY2025 annual figure was $11.0 million, up 99.51% from the prior year.
• Other Accumulated Expenses came in at $7.1 million for Q2 2026 at 10x Genomics, down from $8.4 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $12.8 million in Q2 2025 to a low of $3.3 million in Q2 2023.
• Average Other Accumulated Expenses over 5 years is $7.2 million, with a median of $6.0 million recorded in 2022.
• Year-over-year, Other Accumulated Expenses surged 2398.98% in 2022 and slumped 44.81% in 2026.
• Over 5 years, Other Accumulated Expenses stood at $6.7 million in 2022, then tumbled by 34.2% to $4.4 million in 2023, then advanced by 24.88% to $5.5 million in 2024, then jumped by 99.51% to $11.0 million in 2025, then plunged by 35.65% to $7.1 million in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $7.1 million in Q2 2026, $8.4 million in Q1 2026, and $11.0 million in Q4 2025.